Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Collen

Showing results (691-700 of 715) with videos related to

Pageof 72
Sort By:
Nature Medicine|February 15, 2001
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosisA Angelillo-Scherrer, P de Frutos, C Aparicio, et al.
Circulation|May 23, 2001
Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient miceR Quarck, B De Geest, D Stengel, et al.
Thrombosis and Haemostasis|March 4, 1991
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarctionD C Sane, D C Stump, E J Topol, et al.
Nature Genetics|September 1, 1997
A mouse model for Zellweger syndromeM Baes, P Gressens, E Baumgart, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapyT Vandendriessche, L Thorrez, A Acosta-Sanchez, et al.
The Journal of Clinical Investigation|April 1, 1988
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogsT Yasuda, H K Gold, J T Fallon, et al.
Nature|September 5, 1996
Role of tissue factor in embryonic blood vessel developmentP Carmeliet, N Mackman, L Moons, et al.
Gene|August 6, 1999
Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb elementJ Gabriëls, M C Beckers, H Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathwaysY Y Huang, M E Bach, H P Lipp, et al.
Nature|April 4, 1996
Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleP Carmeliet, V Ferreira, G Breier, et al.
Pageof 72

Showing results (691-700 of 715) with videos related to

Sort By:
Pageof 72
Nature Medicine|February 15, 2001
Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosisA Angelillo-Scherrer, P de Frutos, C Aparicio, et al.
Circulation|May 23, 2001
Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient miceR Quarck, B De Geest, D Stengel, et al.
Thrombosis and Haemostasis|March 4, 1991
Correlation between baseline plasminogen activator inhibitor levels and clinical outcome during therapy with tissue plasminogen activator for acute myocardial infarctionD C Sane, D C Stump, E J Topol, et al.
Nature Genetics|September 1, 1997
A mouse model for Zellweger syndromeM Baes, P Gressens, E Baumgart, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2006
Efficacy and safety of adeno-associated viral vectors based on serotype 8 and 9 vs. lentiviral vectors for hemophilia B gene therapyT Vandendriessche, L Thorrez, A Acosta-Sanchez, et al.
The Journal of Clinical Investigation|April 1, 1988
Monoclonal antibody against the platelet glycoprotein (GP) IIb/IIIa receptor prevents coronary artery reocclusion after reperfusion with recombinant tissue-type plasminogen activator in dogsT Yasuda, H K Gold, J T Fallon, et al.
Nature|September 5, 1996
Role of tissue factor in embryonic blood vessel developmentP Carmeliet, N Mackman, L Moons, et al.
Gene|August 6, 1999
Nucleotide sequence of the partially deleted D4Z4 locus in a patient with FSHD identifies a putative gene within each 3.3 kb elementJ Gabriëls, M C Beckers, H Ding, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 6, 1996
Mice lacking the gene encoding tissue-type plasminogen activator show a selective interference with late-phase long-term potentiation in both Schaffer collateral and mossy fiber pathwaysY Y Huang, M E Bach, H P Lipp, et al.
Nature|April 4, 1996
Abnormal blood vessel development and lethality in embryos lacking a single VEGF alleleP Carmeliet, V Ferreira, G Breier, et al.
Pageof 72